Investigating Health Impacts of Exposure to Harmful Algal Blooms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRoskamp Institute Inc.
About this trial
The goals of this project are to study the biological effects of environmental toxins (ET), in particular aquatic toxins such as brevetoxins (PbTx) and microcystin or their metabolites. This study is designed to examine the effects of the body from harmful algae blooms (HAB) as well as possibility of an association between exposure to the marine toxin, brevetoxin (PbTx), which is released from K. brevis during the red tide bloom, and the prevalence of neurological illnesses.
Eligibility criteria
Qualifiers
Subject should be able to provide written informed consent.
Adult aged 18 or older.
Resident (temporary or permanent) of one of the following five southwest Florida counties (Lee, Collier, Charlotte, Sarasota, or Manatee).
Any race or ethnicity.
Disqualifiers
Inability to speak or write in English.
Any medical condition for which the study investigator believes enrollment is medically inappropriate.
Unwilling/unable to provide biological samples or poor venous access.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
400 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov